SCHEDULE: Vanguard Discloses 8.45% Stake in Astrana Health

The Vanguard Group reported an 8.45% beneficial ownership in Astrana Health Inc. common stock, alongside an internal realignment affecting future reporting.

Summary

• The Vanguard Group beneficially owns 4,238,192 shares of Astrana Health Inc. common stock.
• This ownership represents 8.45% of the class of securities.
• Vanguard holds shared voting power over 341,999 shares and shared dispositive power over 4,238,192 shares.
• An internal realignment within The Vanguard Group, Inc. occurred on January 12, 2026, resulting in the cessation of portfolio management services and proxy voting administration by The Vanguard Group, Inc. itself.
• Following this realignment, certain subsidiaries or business divisions of Vanguard are expected to report beneficial ownership separately (on a disaggregated basis) in reliance on SEC Release No. 34-39538.
• These subsidiaries and/or business divisions will continue to pursue the same investment strategies as previously pursued by The Vanguard Group, Inc.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Astrana Health Inc.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as largely neutral with a slight positive tilt for Astrana Health, as it confirms a substantial, passive institutional ownership stake by Vanguard, despite internal structural changes within Vanguard itself.

Positives

• Vanguard maintains a significant 8.45% beneficial ownership stake in Astrana Health, indicating continued institutional interest.
• The internal realignment within Vanguard is a procedural change and does not signify a divestment or change in the underlying investment strategies for these holdings.

Future Outlook

The Vanguard Group anticipates that certain subsidiaries or business divisions will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. following an internal realignment. These subsidiaries will continue to pursue the same investment strategies.

Management Comments

• "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. As of that date, The Vanguard Group, Inc. no longer performs portfolio management services or administers proxy voting."
• "The Vanguard Group, Inc. anticipates that certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that currently have, or are deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release."
• "These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment."
• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities."

Industry Context

StockSavvy.ai notes that large institutional investors like The Vanguard Group frequently adjust their internal structures for operational efficiency or regulatory compliance. The continued significant stake in Astrana Health, despite the internal realignment, suggests that the underlying investment thesis for the company remains intact across Vanguard's various investment vehicles. This is a common practice among major asset managers to streamline reporting and management responsibilities.

Management Changes

Stakeholder Impact

• Shareholders: Confirms a significant institutional investor (Vanguard) holds a substantial stake, potentially providing stability and liquidity. The internal realignment within Vanguard does not alter the beneficial ownership percentage for Astrana Health.

Next Steps

• Certain Vanguard subsidiaries or business divisions will report beneficial ownership separately (on a disaggregated basis) in future filings.

Key Dates

Recommendation

This Schedule 13G filing primarily serves as a disclosure of beneficial ownership by a major institutional investor, The Vanguard Group, and details an internal organizational change within Vanguard. It does not provide new fundamental information about Astrana Health Inc.'s operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Vanguard's continued significant stake (8.45%) suggests a long-term, passive investment approach, consistent with its index-tracking strategies. Therefore, a 'hold' recommendation is appropriate as there's no new information to alter an existing investment thesis.

Keywords

Astrana Health, Vanguard Group, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Investment Management, Portfolio Management